NRIX
Nurix Therapeutics, Inc. Common stock
$18.91
-4.33%
-0.84
Notify me if price changes either direction
Buy NRIX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.9B
Enterprise value
1.1B
Trailing PE
-6.4444442590078
Forward PE
-5.494747
PEG Ratio
-0.11993826815376
Enterprise to EBITDA
-4.312
Enterprise to revenue
13.364
Price to book MRQ
3.8723667
Price to sales TTM
22.711689
Financials
Fiscal Year Ends
2024-11-30
Most Recent Quarter (MRQ)
2025-08-31
Revenue (TTM)
83.7M
EBITDA
-259359008
Diluted EPS TTM
-2.97
Total Cash (MRQ)
428.8M
Current ratio (MRQ)
5.35
Operating Cash Flow (TTM)
-230384000
NRIX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
